Published in Endothelium on May 26, 2006
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest (2009) 1.56
Semaphorin 4D signaling requires the recruitment of phospholipase C gamma into the plexin-B1 receptor complex. Mol Cell Biol (2009) 0.93
Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. J Clin Invest (2014) 0.92
Immunohistochemical Distribution of PlexinA4 in the Adult Rat Central Nervous System. Front Neuroanat (2010) 0.86
Genetic dissection of plexin signaling in vivo. Proc Natl Acad Sci U S A (2014) 0.84
Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion. BMC Cancer (2010) 0.81
PlexinA4 distribution in the adult rat spinal cord and dorsal root ganglia. J Chem Neuroanat (2012) 0.79
Plexin a4 expression in adult rat cranial nerves. J Chem Neuroanat (2014) 0.75
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature (2003) 3.42
Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET. Clin Cancer Res (2013) 2.61
Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS Biol (2009) 2.16
Integrins and angiogenesis: a sticky business. Exp Cell Res (2005) 1.69
Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood (2005) 1.65
Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol (2005) 1.61
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med (2002) 1.59
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest (2009) 1.56
Diffusion-limited phase separation in eukaryotic chemotaxis. Proc Natl Acad Sci U S A (2005) 1.41
Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell (2004) 1.28
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J (2008) 1.24
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood (2004) 1.21
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J Clin Invest (2012) 1.11
The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling. Cell Res (2012) 1.10
Diacylglycerol kinase alpha mediates HGF-induced Rac activation and membrane ruffling by regulating atypical PKC and RhoGDI. Proc Natl Acad Sci U S A (2010) 1.10
In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J (2001) 1.06
Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA. J Biol Chem (2003) 1.04
CCL16 activates an angiogenic program in vascular endothelial cells. Blood (2003) 1.00
Integrin signaling and lung cancer. Cell Adh Migr (2010) 0.99
The GTPase-activating protein RN-tre controls focal adhesion turnover and cell migration. Curr Biol (2013) 0.97
Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. Blood (2003) 0.97
Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Cancer Res (2003) 0.96
Neuropilin-1-dependent regulation of EGF-receptor signaling. Cancer Res (2012) 0.95
Neuropilin-1 identifies a subset of bone marrow Gr1- monocytes that can induce tumor vessel normalization and inhibit tumor growth. Cancer Res (2012) 0.94
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood (2006) 0.94
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res (2005) 0.93
A bistable model of cell polarity. PLoS One (2012) 0.85
Integrins: a flexible platform for endothelial vascular tyrosine kinase receptors. Autoimmun Rev (2007) 0.85
Nervous vascular parallels: axon guidance and beyond. Int J Dev Biol (2011) 0.84
Polarity, cell division, and out-of-equilibrium dynamics control the growth of epithelial structures. J Cell Biol (2013) 0.84
Microenvironment drives the endothelial or neural fate of differentiating embryonic stem cells coexpressing neuropilin-1 and Flk-1. FASEB J (2008) 0.82
Regulation of adhesion site dynamics by integrin traffic. Curr Opin Cell Biol (2012) 0.81
Increasing traffic on vascular routes. Mol Aspects Med (2011) 0.79
The vesicular SNARE Synaptobrevin is required for Semaphorin 3A axonal repulsion. J Cell Biol (2012) 0.79
Class 3 semaphorin in angiogenesis and lymphangiogenesis. Chem Immunol Allergy (2013) 0.78
Linifanib: current status and future potential in cancer therapy. Expert Rev Anticancer Ther (2015) 0.78
Regulation of integrins by conformation and traffic: it takes two to tango. Mol Biosyst (2011) 0.77
A simulation environment for directional sensing as a phase separation process. Sci STKE (2007) 0.76
Angiogenesis: a balancing act between integrin activation and inhibition? Eur Cytokine Netw (2009) 0.76
Embryonic cleavage modeling as a computational approach to sphere packing problem. J Theor Biol (2006) 0.75